Immuron (IMRN) Assets Growth (1y) (2017 - 2025)
Immuron (IMRN) Assets Growth (1y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Immuron | 6.75 Mn | 6.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | -35.10% |
| Jun 30, 2025 | -36.69% |
| Dec 31, 2024 | 6,048.66% |
| Jun 30, 2024 | 4,560.60% |
| Dec 31, 2023 | -99.21% |
| Jun 30, 2023 | -98.76% |
| Dec 31, 2022 | 8,691.06% |
| Jun 30, 2022 | -14.54% |
| Jun 30, 2021 | 412.48% |
| Jun 30, 2020 | -32.22% |
| Dec 31, 2019 | -99.19% |
| Jun 30, 2019 | -14.29% |
| Dec 31, 2018 | 60.38% |
| Jun 30, 2018 | 12.40% |
| Dec 31, 2017 | -27.89% |
| Jun 30, 2017 | -5.56% |